Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 3
1962 2
1965 1
1966 2
1967 1
1968 2
1969 1
1970 3
1971 1
1972 2
1974 2
1975 2
1977 2
1978 1
1979 1
1980 3
1981 2
1983 1
1984 2
1985 1
1986 2
1990 2
1991 1
1992 2
1993 1
1994 2
1995 2
1996 4
1997 7
1998 8
1999 10
2000 6
2001 13
2002 9
2003 5
2004 3
2005 4
2006 4
2007 4
2008 7
2009 3
2010 9
2011 6
2012 5
2013 9
2014 15
2015 12
2016 20
2017 13
2018 17
2019 16
2020 18
2021 21
2022 10
2023 13
2024 25
2025 22
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

326 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hamamoto w[au] (20 results)?
Distinct impact of RF and ACPA titre on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort study.
Etani Y, Okita Y, Maeda Y, Tsujimoto K, Hirao M, Onishi A, Onizawa H, Okano T, Nishimura K, Yoshikawa A, Shiba H, Amuro H, Son Y, Hashimoto M, Okano T, Hara R, Yamamoto W, Tachibana S, Hayashi S, Noguchi T, Kumanogoh A, Okada S, Nakata K, Ebina K. Etani Y, et al. Among authors: yamamoto w. Mod Rheumatol. 2025 Sep 2;35(5):820-829. doi: 10.1093/mr/roaf029. Mod Rheumatol. 2025. PMID: 40103318
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study.
Watanabe R, Ebina K, Gon T, Okano T, Murata K, Murakami K, Maeda Y, Jinno S, Shirasugi I, Son Y, Amuro H, Katayama M, Hara R, Hata K, Yoshikawa A, Yamamoto W, Tachibana S, Hayashi S, Etani Y, Katsushima M, Fukumoto K, Yamada S, Hashimoto M. Watanabe R, et al. Among authors: yamamoto w. Rheumatology (Oxford). 2024 Sep 1;63(9):2418-2426. doi: 10.1093/rheumatology/keae265. Rheumatology (Oxford). 2024. PMID: 38724245
Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study.
Onishi A, Tanaka M, Fujii T, Murata K, Murakami K, Hashimoto M, Watanabe R, Nozaki Y, Ashida C, Yamamoto W, Yamada H, Sendo S, Ebina K, Makino H, Son Y, Wada Y, Hata K, Matsuda S, Morinobu A. Onishi A, et al. Among authors: yamamoto w. Arthritis Res Ther. 2025 Mar 7;27(1):52. doi: 10.1186/s13075-025-03514-x. Arthritis Res Ther. 2025. PMID: 40055759 Free PMC article.
Hyperproinsulinemia in Japan.
Kanazawa Y, Kuzuya N, Takeuchi Y, Kubo F, Yamamoto W, Noda M. Kanazawa Y, et al. Among authors: yamamoto w. Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S143-4. doi: 10.1016/0168-8227(94)90241-0. Diabetes Res Clin Pract. 1994. PMID: 7859596 Review.
Differential Impact of Concomitant Methotrexate and Glucocorticoids Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort Study.
Ebina K, Etani Y, Okita Y, Tsujimoto K, Maeda Y, Noguchi T, Hirao M, Murata K, Fujii T, Hashimoto M, Okano T, Kotani T, Nagai K, Okano T, Shirasugi I, Hara R, Son Y, Amuro H, Katayama M, Tachibana S, Hayashi S, Yamamoto W, Kumanogoh A, Nakata K, Okada S, Onishi A. Ebina K, et al. Among authors: yamamoto w. Int J Rheum Dis. 2025 Jul;28(7):e70351. doi: 10.1111/1756-185X.70351. Int J Rheum Dis. 2025. PMID: 40589064
Two-Photon-Excited Photoinduced Force Microscopy.
Tamura T, Sagami N, Sasaki T, Yamamoto W, Oketani R, Hiramatsu K. Tamura T, et al. Among authors: yamamoto w. Nano Lett. 2026 Jan 14;26(1):51-57. doi: 10.1021/acs.nanolett.5c04444. Epub 2025 Dec 20. Nano Lett. 2026. PMID: 41420627
Contrast nasopharyngography.
Tada S, Kino M, Yamamoto W, Harada J, Kanehira C. Tada S, et al. Among authors: yamamoto w. Clin Radiol. 1977 Nov;28(6):659-62. doi: 10.1016/s0009-9260(77)80052-4. Clin Radiol. 1977. PMID: 589923
326 results